LONDON, July 10, 2024 (GLOBE NEWSWIRE) - In a recent series of interviews with World Finance, David Barrett, CEO of EBC Financial Group (UK) Ltd, shed light on EBC Financial Group's strategic growth h......
Io Therapeutics, Inc., presented data from studies of IRX4204, the company's phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting it......
SUNRISE, Florida, USA, July 09, 2024 (GLOBE NEWSWIRE) - MedPro International, through its philanthropic Global Giving program, sponsored medical services to more than 300 patients at a one-day event i......
